BIOMARIN PHARMACEUTICAL INC Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax · last filed 2026-02-26
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2025 was $0.00.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2024 was $0.00.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2023 was $0.00.
- BIOMARIN PHARMACEUTICAL INC other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2022 was $0.00.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-24 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-26 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-27 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-25 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 |
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |